378
Participants
Start Date
September 7, 2021
Primary Completion Date
February 28, 2026
Study Completion Date
July 31, 2029
Leucovorin Calcium
IV
Fluorouracil
IV
Irinotecan Hydrochloride
IV
Oxaliplatin
IV
Resection
Open or minimally-invasive pancreatectomy.
RECRUITING
Jeroen Bosch Hospital, 's-Hertogenbosch
RECRUITING
Meander Medical Center, Amersfoort
RECRUITING
Amsterdam UMC, Amsterdam
RECRUITING
OLVG, Amsterdam
RECRUITING
Amphia Hospital, Breda
RECRUITING
Deventer Hospital, Deventer
RECRUITING
Catharina Hospital, Eindhoven
RECRUITING
Medisch Spectrum Twente, Enschede
RECRUITING
University Medical Center Groningen, Groningen
RECRUITING
Tjongerschans Hospital, Heerenveen
RECRUITING
Medical Center Leeuwarden, Leeuwarden
RECRUITING
Leiden University Medical Center, Leiden
RECRUITING
Maastricht UMC+, Maastricht
RECRUITING
Radboud University Medical Center, Nijmegen
RECRUITING
Erasmus MC University Medical Center, Rotterdam
RECRUITING
Maasstad Ziekenhuis, Rotterdam
RECRUITING
Regional Academic Center Utrecht, Antonius Hospital, Utrecht
RECRUITING
Isala Hospital, Zwolle
NOT_YET_RECRUITING
Oslo University Hospital, Oslo
RECRUITING
Sahlgrenska University Hospital, Gothenburg
RECRUITING
Skåne University Hospital, Lund
RECRUITING
Karolinska University Hospital, Stockholm
Lead Sponsor
Dutch Pancreatic Cancer Group
UNKNOWN
Dutch Cancer Society
OTHER
Erasmus Medical Center
OTHER